Jibran Durrani
- Hematology top 10%
- Acute Myeloid Leukemia Research 11
- Hematopoietic Stem Cell Transplantation 5
- Chronic Myeloid Leukemia Treatments 2
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
-
- Cancer Genomics and Diagnostics 4
-
- Epigenetics and DNA Methylation 2
- Histone Deacetylase Inhibitors Research 2
-
- Acute Lymphoblastic Leukemia research 2
- Co-authors
- Jaroslaw P. MaciejewskiFaizan MalikEmma M. GroarkeValeria VisconteRoomasa ChannaKhabir AhmadHetty E. CarrawayMikkael A. Sekeres
- Cited by
- HematologyInternal MedicineGenetics
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Jibran Durrani
23 papers receiving 144 citations
Peers
Comparison fields: 5 of 33
- Hematology 70
- Internal Medicine 15
- Genetics 32
- Immunology 30
- Emergency Medicine 13
Countries citing papers authored by Jibran Durrani
This map shows the geographic impact of Jibran Durrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jibran Durrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jibran Durrani more than expected).
Fields of papers citing papers by Jibran Durrani
This network shows the impact of papers produced by Jibran Durrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jibran Durrani. The network helps show where Jibran Durrani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jibran Durrani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 10 | |
| 6 | 2022 | 8 | |
| 7 | 2020 | 7 | |
| 8 | 2020 | 1 | |
| 9 | 2019 | 23 | |
| 10 | 2019 | 1 | |
| 11 | 2019 | 5 | |
| 12 | 2019 | 2 | |
| 13 | 2019 | 2 | |
| 14 | 2019 | 2 | |
| 15 | 2019 | 11 | |
| 16 | 2019 | 2 | |
| 17 | 2018 | 32 | |
| 18 | 2018 | 2 | |
| 19 | 2010 | 14 | |
| 20 | 1972 | 1 |
About Jibran Durrani
Jibran Durrani is a scholar working on Hematology, Genetics and Internal Medicine, having authored 24 papers that have together received 146 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Hematopoietic Stem Cell Transplantation (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (4 papers), Epigenetics and DNA Methylation (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Hematology (70 citations), Internal Medicine (15 citations) and Genetics (32 citations). Jibran Durrani has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Jaroslaw P. Maciejewski, Faizan Malik, Emma M. Groarke, Valeria Visconte, Roomasa Channa, Khabir Ahmad, Hetty E. Carraway, Mikkael A. Sekeres, Hassan Awada and Ashwin Kishtagari. Their work appears in journals such as Blood, British Journal of Haematology, Ophthalmic Research, Seminars in Hematology and Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.